Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

347 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease.

Kong G, Cao KL, Judd LM, Li S, Renoir T, Hannan AJ.

Neurobiol Dis. 2020 Feb;135:104268. doi: 10.1016/j.nbd.2018.09.001. Epub 2018 Sep 5.

0

0

0

PUBMED

DNA Methylation Profiles in Whole Blood of Huntington's Disease Patients.

Zadel M, Maver A, Kovanda A, Peterlin B.

Front Neurol. 2018 Aug 14;9:655. doi: 10.3389/fneur.2018.00655. eCollection 2018.

0

0

0

PUBMED

Pharmacogenetic modulation of STEP improves motor and cognitive function in a mouse model of Huntington's disease.

García-Forn M, Martínez-Torres S, García-Díaz Barriga G, Alberch J, Milà M, Azkona G, Pérez-Navarro E.

Neurobiol Dis. 2018 Aug 31;120:88-97. doi: 10.1016/j.nbd.2018.08.024. [Epub ahead of print]

0

0

0

PUBMED

Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Holley SM, Kamdjou T, Reidling JC, Fury B, Coleal-Bergum D, Bauer G, Thompson LM, Levine MS, Cepeda C.

CNS Neurosci Ther. 2018 Apr;24(4):329-342. doi: 10.1111/cns.12839. Epub 2018 Mar 6. Review.

0

0

0

PUBMED

Age- and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington's disease.

Padovan-Neto FE, Jurkowski L, Murray C, Stutzmann GE, Kwan M, Ghavami A, Beaumont V, Park LC, West AR.

Nitric Oxide. 2018 Dec 5. pii: S1089-8603(18)30122-8. doi: 10.1016/j.niox.2018.12.002. [Epub ahead of print]

0

0

0

PUBMED

Striatal Neurodegeneration that Mimics Huntington's Disease Modifies GABA-induced Currents.

Flores-Hernández J, Garzón-Vázquez JA, Hernández-Carballo G, Nieto-Mendoza E, Ruíz-Luna EA, Hernández-Echeagaray E.

Brain Sci. 2018 Dec 6;8(12). pii: E217. doi: 10.3390/brainsci8120217.

0

0

0

PUBMED

Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.

El-Abhar H, Abd El Fattah MA, Wadie W, El-Tanbouly DM.

PLoS One. 2018 Sep 27;13(9):e0203837. doi: 10.1371/journal.pone.0203837. eCollection 2018.

0

0

0

PUBMED

Huntington's disease-like disorders in Latin America and the Caribbean.

Walker RH, Gatto EM, Bustamante ML, Bernal-Pacheco O, Cardoso F, Castilhos RM, Chana-Cuevas P, Cornejo-Olivas M, Estrada-Bellmann I, Jardim LB, López-Castellanos R, López-Contreras R, Maia DP, Mazzett

Parkinsonism Relat Disord. 2018 May 21. pii: S1353-8020(18)30253-0. doi: 10.1016/j.parkreldis.2018.05.021. [Epub ahead of print] Review.

0

0

0

PUBMED

Brain pericyte activation occurs early in Huntington's disease.

Padel T, Roth M, Gaceb A, Li JY, Björkqvist M, Paul G.

Exp Neurol. 2018 Jul;305:139-150. doi: 10.1016/j.expneurol.2018.03.015. Epub 2018 Apr 7.

0

0

0

PUBMED

Brain mitochondrial iron accumulates in Huntington's disease, mediates mitochondrial dysfunction, and can be removed pharmacologically.

Agrawal S, Fox J, Thyagarajan B, Fox JH.

Free Radic Biol Med. 2018 May 20;120:317-329. doi: 10.1016/j.freeradbiomed.2018.04.002. Epub 2018 Apr 4.

0

0

0

PUBMED

The influence of motor ability rehabilitation on temporal-spatial parameters of gait in Huntington's disease patients on the basis of a three-dimensional motion analysis system: An experimental trial.

Mirek E, Filip M, Chwała W, Szymura J, Pasiut S, Banaszkiewicz K, Bar MR, Szczudlik A.

Neurol Neurochir Pol. 2018 Feb 12. pii: S0028-3843(17)30182-2. doi: 10.1016/j.pjnns.2018.02.001. [Epub ahead of print]

0

0

0

PUBMED

This could be me: exploring the impact of genetic risk for Huntington's disease young caregivers."

Dondanville DS, Hanson-Kahn AK, Kavanaugh MS, Siskind CE, Fanos JH.

J Community Genet. 2018 Nov 14. doi: 10.1007/s12687-018-0395-z. [Epub ahead of print]

0

0

0

PUBMED

Predicting clinical diagnosis in Huntington's disease: An imaging polymarker.

Mason SL, Daws RE, Soreq E, Johnson EB, Scahill RI, Tabrizi SJ, Barker RA, Hampshire A.

Ann Neurol. 2018 Feb 5. doi: 10.1002/ana.25171. [Epub ahead of print]

0

0

0

PUBMED

Inhibition of Drp1 hyperactivation reduces neuropathology and behavioral deficits in zQ175 knock-in mouse model of Huntington's disease.

Zhao Y, Sun X, Qi X.

Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):319-323. doi: 10.1016/j.bbrc.2018.11.031. Epub 2018 Nov 16.

0

0

0

PUBMED

Reconstituting Corticostriatal Network on-a-Chip Reveals the Contribution of the Presynaptic Compartment to Huntington's Disease.

Virlogeux A, Moutaux E, Christaller W, Genoux A, Bruyère J, Fino E, Charlot B, Cazorla M, Saudou F.

Cell Rep. 2018 Jan 2;22(1):110-122. doi: 10.1016/j.celrep.2017.12.013.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy